1. [Home](https://www.g2.com/)
2. ...
3. [Clinical Trial Management Systems](https://www.g2.com/categories/clinical-trial-management-systems)
4. [Zelthy-Compassionate Access Discussions](https://www.g2.com/products/zelthy-compassionate-access/discuss)

[
 ![Zelthy-Compassionate Access](https://images.g2crowd.com/uploads/product/image/large_detail/large_detail_c609c2ff291c78bc7af13a59416afa68/zelthy-compassionate-access.png "Zelthy-Compassionate Access")
](/products/zelthy-compassionate-access/reviews)

# Zelthy-Compassionate Access Discussions

What is this product? Zelthy Compassionate Access is an application for pharmaceutical companies managing expanded access (compassionate use) programs. It handles the complete program workflow: patient request intake, physician and medical review, ethics committee approval, regulatory filing (FDA, TGA, EMA), and logistics coordination for drug supply — replacing the manual, multi-step approval process that often delays patient access to investigational therapies. Key Features & Functionalities - Patient request intake with physician documentation - Medical review and clinical assessment workflows - Ethics committee approval management - Regulatory filing for FDA, TGA, EMA, and other authorities - Drug supply logistics coordination - Program analytics and reporting Primary Solution & Value Expanded access programs involve a complex multi-step approval chain — medical review, ethics approval, regulatory filing — that can delay patient access to investigational therapies by weeks. This application digitizes the full approval workflow, reducing cycle time while maintaining the documentation required for regulatory compliance.

## Be the first to start the conversation

Get answers from real professionals in the G2 community.